Approval · Notice of Compliance 13790 · 2012
ENFLURANE: Notice of Compliance 13790
Issued November 1, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13790
- Date
- November 1, 2012
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Inhalation anesthetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ENFLURANE | 00778370 | Cancelled Post Market |
Medicinal ingredients
- ENFLURANE 99.9 PER